Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
H.P. Acthar Gel in Dry Eye Disease
NCT03287635Phase 4Completed
- Sponsor
- Toyos Clinic
- Start
- Jul 2018
- Primary completion
- Feb 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of repository corticotropin injection in dry eye disease (DED), sponsored by Toyos Clinic. Started Jul 2018; status: completed.
02
Drugs
repository corticotropin injection
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT03287635.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03287635.